TTUHSC researcher receives $1.76 million grant to investigate new pancreatic cancer treatment

With a survival rate in the single digits, pancreatic ductal adenocarcinoma (PDAC) is highly lethal. In fact, by the time PDAC is clinically diagnosed, it is already considered incurable via surgery or other means in up to 90% of patients.

Genetic Leap, Eli Lilly Partner to Advance RNA Genetic Medicine

What You Should Know: – Genetic Leap, a pioneering AI-native techbio company, has entered into a strategic research collaboration with Eli Lilly and Company. –

September 6, 2024

RM-191A by RR MedSciences for Neuropathic Pain (Neuralgia): Likelihood of Approval

RM-191A is under clinical development by RR MedSciences and currently in Phase II for Neuropathic Pain (Neuralgia).

February 20, 2024

Genomic Testing in Endometrial Cancer

Genomic testing matters in endometrial cancer both for prognostication and therapeutic selection, but there’s work to do in making sure it reaches all women. “It

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.